Mednet Logo
HomeOphthalmology
Ophthalmology

Ophthalmology

Expert insights on ocular conditions, surgical techniques, retinal disease, and vision-related management.

Recent Discussions

What recommendations do you provide to patients who develop ocular side effects with Dupixent?

2
3 Answers

Mednet Member
Mednet Member
Dermatology · University of Pennsylvania School of Medicine

I would start with over-the-counter artificial tears without preservative and then refer to an ophthalmologist, ideally a corneal specialist who is experienced in the nuances of treating this condition. I have also had success switching from Dupixent to Adbry, although JAK inhibitors are a better o...

What is the role of femtosecond laser–assisted techniques in pediatric cataracts?

1
1 Answers

Mednet Member
Mednet Member
Ophthalmology · University of Colorado

Theoretically, FLACS would be a great tool for pediatric cataracts because the anterior capsule in children is elastic and can be quite unpredictable, making the capsulorhexis step one of the most challenging in the procedure. FLACS would potentially minimize the complication rate in this step. Pati...

Is there any role for topical corticosteroids in the treatment of photokeratitis?

1
2 Answers

Mednet Member
Mednet Member
Ophthalmology · Alkek Eye Center

Typically not, as this is not an inflammatory condition. The goal is to provide supportive care with aggressive lubrication and pain control with topical cycloplegics until epithelial regeneration occurs.

Do you stop netarsudil or brimonidine for patients with very injected conjunctiva prior to trabeculectomy, and what do you feel is the benefit?

2
1 Answers

Mednet Member
Mednet Member
Ophthalmology · Russellville Eye Clinic Pa

I find Rhopressa helpful in lowering IOP pre-op surgery, but it can cause inflamed conjunctiva, so I stop 1 week prior to surgery and prefer brimonidine 0.15% (Alphagan P), and it may have neuroprotective value as well.

What is your approach to intralesional steroid injection for chalazia (in terms of dosage, approach, timing)?

2
3 Answers

Mednet Member
Mednet Member
Ophthalmology · Triad Ocular and Facial Plastic Surgery

I offer the option of intralesional steroid to all patients with chalazia, particularly if there is significant inflammation present. I give up to 1 cc of a 10 mg/mL solution of dexamethasone. I have approached this by both transconjunctival as well as transcutaneous. I think transconjunctival hurts...

How would you approach a patient with vitreoretinal lymphoma without CNS or systemic involvement?

1
2 Answers

Mednet Member
Mednet Member
Radiation Oncology · Duke University Medical Center

The optimal treatment approach for primary intraocular lymphoma is debated. This is a rare disease with only small retrospective series guiding therapy. There is no clear superior treatment approach in the literature. In clinical practice, younger patients are often treated initially with high-dose ...

When do you consider adding steroids alongside intravenous antibiotics for patients with orbital cellulitis?

1
5 Answers

Mednet Member
Mednet Member
Ophthalmology · Advanced Eye Centers Inc

If the orbital cellulitis is infectious, I never add steroids. There is no literature or proof that they do anything, and decreasing immunity, in my opinion, is simply a bad idea. If it is inflammatory, then absolutely. Most infectious orbital cellulitis is from the sinuses and is more common in chi...

How would you advise a younger patient with residual/recurrent optic nerve meningioma, proceeding with radiotherapy, about the risks of malignant transformation or induction of other brain malignancies because of radiation?

2
2 Answers

Mednet Member
Mednet Member
Radiation Oncology · GammaWest Cancer Services

The risk of malignant transformation of an optic nerve sheath meningioma (ONSM) after RT appears to be remarkably low, much lower than the risk of blindness from an untreated, progressive ONSM. In a younger patient, I would lean toward RT for patients with imaging progression or early visual loss, ...

What has been your experience both intra-op and post-op with different non-valved implants (Baerveldt vs. Clearpath)?

1
2 Answers

Mednet Member
Mednet Member
Ophthalmology · University of Michigan

In general, all 3 non-valved implant styles available in the US (Baerveldt, Clearpath, and Molteno) work quite similarly, and utilize similar techniques regarding ligation, tube modifications to create early flow anterior to the capsule, and postoperative course. The Molteno implants are slightly na...

How do you approach the treatment of "normal tension glaucoma" and how do you discuss this with patients?

4
4 Answers

Mednet Member
Mednet Member
Ophthalmology · Advanced Eye Centers Inc

It highlights that glaucoma is probably not an eye pressure disease, but rather a vascular disease. As noted above, there is a genetic component clearly, but vasculopaths (DM, Sleep apnea, CVD, etc.) increase that risk with the same IOP.